Annual Meeting Archives
2016
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China
Category:
New Processes, New Materials, New Products
Institutions:
(1) University of North Carolina at Chapel Hill and North Carolina State University, U.S.A.; (2) North Carolina State University, U.S.A.
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Just Biotherapeutics, U.S.A.
Category:
Transdermal Delivery
Institutions:
(1) Lubrizol, U.S.A.; (2) Ernest Mario School of Pharmacy and Center for Dermal Research, Rutgers, U.S.A.; (3) Ernest Mario School of Pharmacy and Center for Dermal Research, Rutgers – The State University of New Jersey, U.S.A.
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) Kyoto Pharmaceutical University, Japan; (2) Shujitsu University, Japan; (3) Tokyo University of Pharmacy and Life Sciences, Japan
Category:
Local Drug Delivery
Institutions:
(1) Tokyo University of Agriculture and Technology, Japan
Category:
New Processes, New Materials, New Products
Institutions:
(1) Keio University, Japan
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, U.S.A.; (2) Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan
Category:
New Processes, New Materials, New Products
Institutions:
(1) The Catholic University of Korea, Korea
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) KAIST, South Korea; (2) Samsung Medical Center, South Korea; (3) Hanyang University, South Korea
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Italian Institute of Technology, Italy
Category:
Preclinical Science Challenges to Drug Delivery
Institutions:
(1) Massachusetts General Hospital & Harvard Medical School, U.S.A.; (2) Massachusetts General Hospital, U.S.A.; (3) Shriners Hospitals for Children, U.S.A.
Category:
Local Drug Delivery
Institutions:
(1) Queen's University Belfast, United Kingdom; (2) PATH, U.S.A.
Category:
Ocular Drug Delivery
Institutions:
(1) Faculty of Pharmacy-Cairo University, Egypt
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Brigham Young University, U.S.A.
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) University of Pittsburgh, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Purdue University, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Indian Institute of Technology Bombay, India
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Oxford, United Kingdom
Category:
Ocular Drug Delivery
Institutions:
(1) School of Pharmacy, the University of Queensland, Australia; (2) Buchanan Ocular Therapeutics Unit, School of Medicine, the University of Auckland, New Zealand
Category:
Oral Delivery
Institutions:
(1) AbbVie, U.S.A.
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) Kobe Gakuin University, Japan; (2) Suez Canal University, Egypt; (3) Toray Industries, Inc., Japan
Using combinatorial biology to develop design principles for mucus-penetrating drug delivery systems
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) The University of Texas at Austin, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) The University of Iowa, U.S.A.
Category:
Transdermal Delivery
Institutions:
(1) EMD Millipore Corp., U.S.A.